Shigekazu Fujita

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 10 EPO patents. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 2008-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigekazu Fujita. Retrieved from https://idiyas.com/inventor/shigekazu-fujita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 41.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 11)

Average Co-Inventor Count = 8.8

ph-index = 3

Forward Citations = 15(Granted Patents)

Location History:

Naruto, JP (2008 - 2012)
Okazaki, JP (2010 - 2013)
Osaka, JP (2013 - 2023)

Company Filing History:

12 out of 846

Otsuka Pharmaceutical Company, Limited

patents

Years Active: 2008-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11673878 - Benzazepine derivatives (2023-06-13),

2. 10889570 - Benzazepine derivatives (2021-01-12),

3. 10626095 - Cyanotriazole compounds (2020-04-21),

4. 8722663 - Di-substituted pyridine derivatives as anticancers (2014-05-13),

5. 8551999 - Heterocyclic compound and pharmaceutical composition thereof (2013-10-08),

6. 8501730 - Process for preparing benzazepine compounds or salts thereof (2013-08-06),

7. 8273735 - Process for preparing benzazepine compounds or salts thereof (2012-09-25),

8. 8222276 - Amine salt of carbostyril derivative (2012-07-17),

9. 8129544 - 1-substituted-4-nitroimidazole compound and method for preparing the same (2012-03-06),

10. 7807843 - 1-substituted-4-nitroimidazole compound and method for preparing the same (2010-10-05),

11. 7732611 - Amine salt of carbostyril derivative (2010-06-08),

12. 7368579 - 1-substituted-4-nitroimidazole compound and process for producing the same (2008-05-06),

Title: Shigekazu Fujita: Innovator in Benzazepine Derivatives

Introduction

Shigekazu Fujita is a prominent inventor based in Okazaki, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel benzazepine compounds. With a total of 12 patents to his name, Fujita's work has had a substantial impact on medical research and pharmaceutical applications.

Latest Patents

Fujita's latest patents focus on benzazepine derivatives. These innovative compounds are designed to exhibit vasopressin V and V antagonisms, which have important medical uses. The patents detail the chemical structure of these compounds, including various substituents and hydrocarbon rings, which enhance their therapeutic potential.

Career Highlights

Shigekazu Fujita is currently employed at Otsuka Pharmaceutical Company, Limited, where he continues to advance his research in medicinal chemistry. His work has been instrumental in developing new therapeutic agents that address various medical conditions. His dedication to innovation in the pharmaceutical industry is evident through his numerous patents and ongoing research efforts.

Collaborations

Fujita has collaborated with notable colleagues, including Naoto Utsumi and Fumitaka Goto. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research.

Conclusion

Shigekazu Fujita is a distinguished inventor whose work in benzazepine derivatives has made a significant impact on the field of medicinal chemistry. His contributions continue to influence pharmaceutical research and development, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.